RecruitingNot Applicable

Constitution of a Cohort for Monitoring Patients Candidating for Ovarian Tissue Autograft

France240 participantsStarted 2013-05

Plain-language summary

Ovarian cryopreservation is one of the available option for preserving fertility prior to potentially sterilizing treatments. In the absence of other techniques such as in vitro folliculogenesis or injection of isolated ovarian follicles, this tissue can only be re-used by autograft. In France, the first live birth after orthotopic ovarian transplantation, was obtained by Roux et al. in 2009. This clinical trial aims to build a cohort of patients likely to use their ovarian tissue cryopreserved by autograft.

Who can participate

Age range11 Years – 43 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who have cryopreserved their ovarian tissue; * Patients with premature ovarian insufficiency; * Patients older than 11 years (bone age) for induction of puberty; * Patients aged from 18 to 43 years for the restoration of ovarian function; * No objection from the patient * Patients who have already received ovarian tissue autograft. Exclusion Criteria: * Patients aged under 11 years (bone age); * Patients older than 43 years; * Patients refusing to be included; * Patients (adults) under guardianship, curators and safeguard justice

What they're measuring

Number of patient who are candidate to ovarian tissue autograft

Timeframe: 5 years

Trial details

NCT IDNCT02855827

SponsorCentre Hospitalier Universitaire de Besancon

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-10

Contact for this trial

Chlotilde AMIOT, MD, PhD

camiot@chu-besancon.fr

View on ClinicalTrials.gov More Ovarian Function Insufficiency trials